BridgeBio Pharma, Inc. (BBIO)
68.14
-2.58
(-3.65%)
USD |
NASDAQ |
Feb 20, 16:00
68.70
+0.56
(+0.82%)
Pre-Market: 20:00
BridgeBio Pharma Shareholders Equity (Quarterly) : -1.933B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 738.98M |
| Mirum Pharmaceuticals, Inc. | 292.05M |
| Cogent Biosciences, Inc. | 636.37M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Sarepta Therapeutics, Inc. | 1.320B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 998.25M |
| Total Liabilities (Quarterly) | 2.921B |
| Debt to Equity Ratio | -1.399 |
| Current Ratio | 3.875 |
| Net Debt Paydown Yield | -1.95% |